Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo

N. Concin
  • Clinical Cancer Research, December 2005, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1078-0432.ccr-05-0899

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Rafał Watrowski